Treating prostate cancer with cryotherapy: Richard Hayden's success
Richard Hayden is a quick-witted 80-year-old living in Manhattan. He enjoys being healthy and active; taking advantage of all that New York City has to offer during his retired years.
Earlier this year, during a routine visit with his primary care physician, he was told that his prostate-specific antigen (referred to as "PSA") levels were abnormally high. Richard was then referred to Dr. Loo, a urologist at Weill Cornell Medicine. After several more blood tests, Dr. Loo became concerned about the potential of prostate cancer.
Cryotherapy and prostate cancer
If you've been diagnosed with prostate cancer, determining your treatment plan can be stressful and overwhelming. There is no single "best" course of action; it depends on you, your lifestyle goals, and your specific type of cancer.
Prostate cancer can be treated with active surveillance, radiation therapy, medical & hormone therapies, surgery, and various ablation procedures such as cryotherapy. Prostate cancer specialists, such as the Urologic Oncologists at Weill Cornell Medicine, will help you customize the right treatment plan for you.
Dr. Barbieri - Interview with an Expert: Active Surveillance
Christopher Barbieri, M.D., Ph.D., Assistant Professor in Urology and in Cell & Developmental Biology at Weill Cornell Medicine, was interviewed by the Prostate Cancer Foundation on active surveillance for prostate cancer patients. He addresses many of the common questions that patients and providers ask regarding eligibility for active surveillance and treatment protocol.
Weill Cornell Medicine Research Highlighted by Prostate Cancer Foundation’s “Top 5 Prostate Cancer Research Stories of 2017”
In January 2018, the Prostate Cancer Foundation recognized the developments of PSMA radionuclide therapy as one of the top 5 research stories of 2017, highlighting the recent work from Weill Cornell Medicine’s Department of Urology as a driving force behind this effort.
Dr. Jim Hu - Active Surveillance and MRI Targeted Biopsies (Prostate Cancer)
Jim C. Hu, M.D., M.P.H. discusses the challenges of accurate risk stratification, explains the benefits of targeted prostate biopsy, and looks at several studies that followed men on active surveillance.
Dr. Jim Hu - Salvage Treatments Following Failed Radiation (Prostate Cancer)
Jim C. Hu, M.D., M.P.H. discusses various options for men with prostate cancer who have failed initial radiation therapy. Looking at several recent studies, he discusses some of the pros & cons of each approach, from both cancer control and quality of life perspectives.
Dr. Douglas Scherr - Surgery for Localized Prostate Cancer
In this video, urologist Dr. Douglas Scherr speaks at an US TOO NY prostate cancer event to discuss the history & evolution of prostate surgery, detailing the current role that surgery can play for patients with localized prostate cancer.
Gerald J. Wang
Dr. Wang received his bachelor of science degree from Yale University in Molecular Biophysics and Biochemistry, and he completed his M.D. degree at Stanford University School of Medicine. He completed his surgical internship and urology residency at Weill Cornell Medical College/NewYork-Presbyterian Hospital. After residency, he completed a fellowship in urologic oncology at Weill Cornell Medical College/NewYork-Presbyterian Hospital. Upon completion of fellowship training, Dr. Wang became Chief of Urology at NewYork-Presbyterian Queens in 2010.
Dr. Barbieri - Individualized Treatments for Prostate Cancer at Weill Cornell Medicine
To make an appointment with NYC urologist and prostate cancer specialist Dr. Christopher Barbieri, please call our office at (212) 746-5562.
For other inquires and additional providers specializing in prostate cancer care at Weill Cornell Medicine in New York City, please call our office at (646) 962-9600.